doc, can you provide a little color on NEWS2. It sounds like an early warning system for those patients who may develop the more serious, even fatal, side effects. Is that an oversimplification? They sounded very excited about NEWS2 on the CC. Perhaps it will be a new end point for future trials, not only with CYDY, but other biotech and pharma companies.